CervoMed Inc. Files 8-K with Regulatory Updates
Ticker: CRVO · Form: 8-K · Filed: May 19, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-disclosure, financial-reporting, company-history
TL;DR
CervoMed filed an 8-K on 5/19/25 for Reg FD disclosure & financials. Formerly Diffusion Pharma.
AI Summary
CervoMed Inc. filed an 8-K on May 19, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This filing provides important updates on CervoMed Inc.'s regulatory compliance and financial reporting, which are crucial for investors to understand the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any significant negative news or events.
Key Numbers
- 20250519 — Filing Date (Date of earliest event reported)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former company name
- RestorGenex Corp (company) — Former company name
- Stratus Media Group, Inc (company) — Former company name
- 0001053691 (company) — Central Index Key
- 300645032 (company) — EIN
- 001-37942 (company) — SEC File Number
- 20 Park Plaza , Suite 424 Boston , Massachusetts 02116 (company) — Business Address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is CervoMed Inc.'s Central Index Key (CIK)?
CervoMed Inc.'s Central Index Key (CIK) is 0001053691.
When was CervoMed Inc. previously known by other names?
CervoMed Inc. was formerly known as Diffusion Pharmaceuticals Inc. (name change 20160115), RestorGenex Corp (name change 20140307), and Stratus Media Group, Inc (name change 20080722).
What is the company's principal executive office address?
The company's principal executive office is located at 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
What is the SEC File Number for CervoMed Inc.?
The SEC File Number for CervoMed Inc. is 001-37942.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding CervoMed Inc. (CRVO).